Clinical Trials
4 trialsNCT00897702 2026-01-28
Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer
Memorial Sloan Kettering Cancer Center
Completed
NCT00470574 2020-11-18
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00847171 2018-09-26
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00821964 2018-01-02
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
University of Washington
Phase 2 Completed